Published in Eur J Clin Microbiol Infect Dis on July 01, 2005
Nationwide high prevalence of CTX-M and an increase of CTX-M-55 in Escherichia coli isolated from patients with community-onset infections in Chinese county hospitals. BMC Infect Dis (2014) 1.13
Use of Cepheid Xpert Carba-R® for Rapid Detection of Carbapenemase-Producing Bacteria in Abdominal Septic Patients Admitted to Intensive Care Unit. PLoS One (2016) 1.03
Antimicrobial treatment of "complicated" intra-abdominal infections and the new IDSA guidelines ? a commentary and an alternative European approach according to clinical definitions. Eur J Med Res (2011) 1.00
Introduction of ertapenem into a hospital formulary: effect on antimicrobial usage and improved in vitro susceptibility of Pseudomonas aeruginosa. Antimicrob Agents Chemother (2009) 0.94
Effect of carbapenem administration on establishment of intestinal colonization by vancomycin-resistant enterococci and Klebsiella pneumoniae in mice. Antimicrob Agents Chemother (2006) 0.90
Pro/con debate: Should antimicrobial stewardship programs be adopted universally in the intensive care unit? Crit Care (2010) 0.86
Effects of imipenem-cilastatin, ertapenem, piperacillin-tazobactam, and ceftriaxone treatments on persistence of intestinal colonization by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae strains in mice. Antimicrob Agents Chemother (2007) 0.80
Antimicrobial prophylaxis in colorectal surgery: focus on ertapenem. Ther Clin Risk Manag (2009) 0.75
Antimicrobial Resistance and Molecular Epidemiology of ESBL-Producing Escherichia coli Isolated from Outpatients in Town Hospitals of Shandong Province, China. Front Microbiol (2017) 0.75
Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials. BMC Infect Dis (2009) 0.75
The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med (2003) 32.30
Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest (1999) 7.40
Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis (2002) 6.76
Vancomycin-resistant enterococcal infections. N Engl J Med (2000) 5.51
Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA (1998) 5.20
Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med (2000) 5.08
International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections. Ann Intern Med (2004) 4.75
SOS response promotes horizontal dissemination of antibiotic resistance genes. Nature (2003) 4.42
Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol (2001) 4.19
Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA (2003) 4.09
The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin Infect Dis (2004) 3.45
The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med (2002) 2.97
Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis (2003) 2.92
Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis (2001) 2.68
"Collateral damage" from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis (2004) 2.48
Spread of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: are beta-lactamase inhibitors of therapeutic value? Clin Infect Dis (1998) 2.20
Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species. Arch Intern Med (2002) 2.00
Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms. Clin Infect Dis (2002) 1.62
Effect of broad-spectrum cephalosporins on the microbial flora of recipients. J Infect Dis (1983) 1.52
Patients' endogenous flora as the source of "nosocomial" Enterobacter in cardiac surgery. J Infect Dis (1987) 1.49
The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: an executive summary. Surg Infect (Larchmt) (2002) 1.47
Effect of parenteral antibiotic administration on establishment of intestinal colonization in mice by Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother (2003) 1.40
Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals. Emerg Infect Dis (2002) 1.40
Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial. Ann Surg (2003) 1.30
Antianaerobic antibiotic therapy promotes overgrowth of antibiotic-resistant, gram-negative bacilli and vancomycin-resistant enterococci in the stool of colonized patients. Infect Control Hosp Epidemiol (2003) 1.23
Ertapenem, the first of a new group of carbapenems. J Antimicrob Chemother (2003) 1.22
Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli. Am J Med (1997) 1.17
Third generation cephalosporin-resistant gram-negative bacilli in the feces of hospitalized children. Pediatr Infect Dis J (1995) 0.82
Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults. Int J Antimicrob Agents (2002) 0.82
Effect of a broad-spectrum cephalosporin on the oral and intestinal microflora in patients undergoing colorectal surgery. J Chemother (1992) 0.78
Influence of cephalosporines III generation with varying biliary excretion on fecal flora and emergence of resistant bacteria during and after cessation of therapy. Padiatr Padol (1986) 0.77
[Influence of ceftriaxone on bacterial flora in human feces]. Jpn J Antibiot (1985) 0.75
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature (1995) 10.13
Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med (1991) 5.85
Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA (1999) 5.26
Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections. J Infect Dis (1986) 4.92
DNA sequence of the region in the genome of herpes simplex virus type 1 containing the genes for DNA polymerase and the major DNA binding protein. Nucleic Acids Res (1985) 4.84
Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership. JAMA (1996) 4.80
Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor. J Virol (1996) 4.45
Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet (2001) 3.94
Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients. Antimicrob Agents Chemother (1992) 3.31
Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J Am Geriatr Soc (2001) 3.06
The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med (1998) 2.94
Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proc Natl Acad Sci U S A (1999) 2.75
A novel chromosomal TEM derivative and alterations in outer membrane proteins together mediate selective ceftazidime resistance in Escherichia coli. J Infect Dis (1990) 2.63
Transfusion-associated acquired immunodeficiency syndrome. Evidence for persistent infection in blood donors. N Engl J Med (1985) 2.62
Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2005) 2.53
Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis (1996) 2.49
Identity and interspecific transfer of gentamicin-resistance plasmids in Staphylococcus aureus and Staphylococcus epidermidis. J Infect Dis (1980) 2.48
Are active microbiological surveillance and subsequent isolation needed to prevent the spread of methicillin-resistant Staphylococcus aureus? Clin Infect Dis (2005) 2.47
Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infect Dis (2001) 2.46
Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet (1996) 2.44
A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med (1996) 2.38
Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline. Chest (2000) 2.36
First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-beta-lactamase (VIM-2) in the United States. Antimicrob Agents Chemother (2005) 2.29
SME-type carbapenem-hydrolyzing class A beta-lactamases from geographically diverse Serratia marcescens strains. Antimicrob Agents Chemother (2000) 2.15
Treatment of fungal peritonitis complicating continuous ambulatory peritoneal dialysis with oral fluconazole: a series of 21 patients. Nephrol Dial Transplant (1994) 2.11
Drug resistance and predicted virologic responses to human immunodeficiency virus type 1 protease inhibitor therapy. J Infect Dis (2000) 2.10
Coexisting stable conformations of gaseous protein ions. Proc Natl Acad Sci U S A (1993) 2.03
Genetically diverse ceftazidime-resistant isolates from a single center: biochemical and genetic characterization of TEM-10 beta-lactamases encoded by different nucleotide sequences. Antimicrob Agents Chemother (1993) 2.03
Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. Clin Infect Dis (1996) 2.03
In vitro susceptibilities of Aeromonas hydrophila, Aeromonas sobria, and Aeromonas caviae to 22 antimicrobial agents. Antimicrob Agents Chemother (1985) 2.03
Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli. Clin Infect Dis (2002) 2.00
Modulation by applied electric fields of Purkinje and stellate cell activity in the isolated turtle cerebellum. J Physiol (1986) 2.00
Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods. J Clin Microbiol (2009) 1.99
Epidemics of nosocomial urinary tract infection caused by multiply resistant gram-negative bacilli: epidemiology and control. J Infect Dis (1976) 1.92
Structural and phenotypic varieties of gentamicin resistance plasmids in hospital strains of Staphylococcus aureus and coagulase-negative staphylococci. Antimicrob Agents Chemother (1982) 1.89
Pseudoepidemics in hospital. Lancet (1977) 1.89
Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment. Ann Oncol (2006) 1.81
High-level quinolone resistance in clinical isolates of Campylobacter jejuni. J Infect Dis (1992) 1.74
Breast abscess: coagulase-negative staphylococcus as a sole pathogen. Clin Infect Dis (1993) 1.72
Diagnosis of pulmonary tuberculosis by detection of tuberculostearic acid in sputum by using gas chromatography-mass spectrometry with selected ion monitoring. J Infect Dis (1987) 1.69
Plasmodium falciparum: loss of knobs on the infected erythrocyte surface after long-term cultivation. Exp Parasitol (1979) 1.69
External sources of vancomycin-resistant enterococci for intensive care units. Crit Care Med (1998) 1.59
Hospital outbreaks caused by Pseudomonas aeruginosa: importance of serogroup O11. J Clin Microbiol (1982) 1.58
Gentamicin-resistant staphylococci as hospital flora: epidemiology and resistance plasmids. J Infect Dis (1982) 1.54
Association of infection caused by Pseudomonas aeruginosa serotype O11 with intravenous abuse of pentazocine mixed with tripelennamine. J Clin Microbiol (1984) 1.54
AIDS-related Pneumocystis carinii pneumonia in older patients. J Gen Intern Med (1996) 1.54
Stability of vancomycin-resistant enterococcal genotypes isolated from long-term-colonized patients. J Infect Dis (1998) 1.53
Variations in intensive care unit utilization for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia: importance of hospital characteristics and geographic location. Crit Care Med (1998) 1.52
A rapid high-performance liquid chromatographic assay for cefepime, cefpirome and meropenem. J Antimicrob Chemother (1998) 1.50
Patients' endogenous flora as the source of "nosocomial" Enterobacter in cardiac surgery. J Infect Dis (1987) 1.49
Relationship between procedures and health insurance for critically ill patients with Pneumocystis carinii pneumonia. Am J Respir Crit Care Med (1995) 1.48
Epidemiology of endemic Pseudomonas aeruginosa: why infection control efforts have failed. J Infect Dis (1984) 1.46
Inhibition of the in vitro growth of Plasmodium falciparum. I. The effects of immune serum and purified immunoglobulin from owl monkeys. J Immunol (1979) 1.45
Diphtheria in the United States, 1971-81. Am J Public Health (1985) 1.44
Diagnosis of tuberculous pleural effusion by the detection of tuberculostearic acid in pleural aspirates. Chest (1991) 1.43
Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell Mol Neurobiol (1996) 1.42
Starting a laparoscopic hepatectomy programme. Singapore Med J (2009) 1.42
Pseudomonas cepacia suppression of sunflower wilt fungus and role of antifungal compounds in controlling the disease. Appl Environ Microbiol (1992) 1.41
Early detection of false-positive acid-fast smears. An epidemiological approach. Lancet (1975) 1.39
A randomized prospective comparison of oral versus intraperitoneal ciprofloxacin as the primary treatment of peritonitis complicating continuous ambulatory peritoneal dialysis. Perit Dial Int (1993) 1.39
Diagnosis of tuberculous meningitis by detection of tuberculostearic acid in cerebrospinal fluid. Lancet (1987) 1.38
Immunogenicity of inactivated hepatitis A vaccine in children. Gastroenterology (1993) 1.38
Magnitude and prevention of nosocomial infections in the intensive care unit. Infect Dis Clin North Am (1997) 1.37
Variations in institutional review board decisions for HIV quality of care studies: a potential source of study bias. J Acquir Immune Defic Syndr (2001) 1.36
Effectiveness of gloves in the prevention of hand carriage of vancomycin-resistant enterococcus species by health care workers after patient care. Clin Infect Dis (2001) 1.36
Immunization of HIV-infected children with varicella vaccine. J Pediatr (2001) 1.35
Rapid detection of positive blood cultures with the BACTEC NR-660 does not require first-day subculturing. J Clin Microbiol (1988) 1.33
Pressure monitoring devices. Overlooked source of nosocomial infection. JAMA (1976) 1.31
A splice variant of the neuron-restrictive silencer factor repressor is expressed in small cell lung cancer: a potential role in derepression of neuroendocrine genes and a useful clinical marker. Cancer Res (2000) 1.31
Magnetic resonance imaging for the detection of nasopharyngeal carcinoma. AJNR Am J Neuroradiol (2006) 1.31
Comparison of endemic and epidemic nosocomial infections. Am J Med (1981) 1.31
Some observations on the epidemiology of toxoplasmosis in Canada. J Hyg (Lond) (1976) 1.31
Cephalothin susceptibility as a potential marker for the Aeromonas sobria group. J Clin Microbiol (1985) 1.30
Improvements in outcomes of acute respiratory failure for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia. Am J Respir Crit Care Med (2000) 1.30
fos/jun and octamer-binding protein interact with a common site in a negative element of the human c-myc gene. J Biol Chem (1989) 1.28
Multiresistant bacteria as a hospital epidemic problem. Ann Med (1998) 1.27
Cellular immunity to varicella-zoster virus in patients with major depression. J Infect Dis (1998) 1.27
The dopamine transporter gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons. J Neurochem (2001) 1.27
Reaction of immune sera with components of the human malarial parasite, Plasmodium falciparum. Am J Trop Med Hyg (1981) 1.27
Selective imipenem resistance in Pseudomonas aeruginosa associated with diminished outer membrane permeability. Antimicrob Agents Chemother (1988) 1.26
Endemic emergence of cephalosporin-resistant Enterobacter: relation to prior therapy. Infect Control (1986) 1.26
High-resolution tandem mass spectrometry of large biomolecules. Proc Natl Acad Sci U S A (1992) 1.26
An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells. FEBS Lett (1999) 1.25
Broad-spectrum beta-lactam resistance in Enterobacter: emergence during treatment and mechanisms of resistance. J Antimicrob Chemother (1983) 1.24
An outbreak of pneumocystis pneumonia in children with acute lymphocytic leukemia. Am J Dis Child (1978) 1.22
Endemic aminoglycoside resistance in gram-negative bacilli: epidemiology and mechanisms. J Infect Dis (1980) 1.20
Occult aminoglycoside resistance in Pseudomonas aeruginosa: epidemiology and implications for therapy and control. J Infect Dis (1985) 1.19
Effect of desiccation on the ultrastructural appearances of Acinetobacter baumannii and Acinetobacter lwoffii. J Clin Pathol (1998) 1.18
The epidemiology of Pseudomonas aeruginosa in oncology patients in a general hospital. J Infect Dis (1989) 1.17
Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med (1998) 1.17
Permanent anatomic closure of the ductus arteriosus in newborn baboons: the roles of postnatal constriction, hypoxia, and gestation. Pediatr Res (1999) 1.17
In-vitro activity of quinolones and macrolides against mycobacteria. J Antimicrob Chemother (1994) 1.15
The impact of traveling to endemic areas on the spread of hepatitis E virus infection: epidemiological and molecular analyses. Hepatology (1998) 1.15